Here, we report the case of a Chinese woman with PFBC due to a novel SLC20A2 variant, who presented with parkinsonism while responding well to dopaminergic therapy, exhibiting symptom fluctuations and levodopa-induced dyskinesia during progression. This evidence concerns the gene SLC20A2 and Parkinson disease.